Cimigenoside enhances Taxol chemosensitivity in triple-negative breast cancer via the γ-secretase/RBPJ-PXR axis.
Saved in:
| Title: | Cimigenoside enhances Taxol chemosensitivity in triple-negative breast cancer via the γ-secretase/RBPJ-PXR axis. |
|---|---|
| Authors: | Feng M; Department of Pathology and Pathophysiology, School of Basic Medical Sciences, Shenyang Medical College, Shenyang, China., Yang X; Department of Endocrinology, General Hospital of Northern Theater Command, Shenyang, China., Yao K; Department of Pathology and Pathophysiology, School of Basic Medical Sciences, Shenyang Medical College, Shenyang, China., Yang KF; Department of Pathology and Pathophysiology, School of Basic Medical Sciences, Shenyang Medical College, Shenyang, China., Zhan XY; School of Traditional Chinese Medicine, Shenyang Medical College, Shenyang, China., Zhou MS; Science and Experimental Research Center of Shenyang Medical College, Shenyang, China.; Shenyang Key Laboratory of Vascular Biology, Shenyang, China., Jia H; School of Traditional Chinese Medicine, Shenyang Medical College, Shenyang, China.; Shenyang Key Laboratory of Vascular Biology, Shenyang, China. |
| Source: | British journal of pharmacology [Br J Pharmacol] 2026 Jul; Vol. 183 (13), pp. 3666-3684. Date of Electronic Publication: 2026 Apr 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
